Silence Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Silence Therapeutics has a total shareholder equity of £123.9M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £194.4M and £70.5M respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
Interest coverage ratio | n/a |
Cash | UK£152.75m |
Equity | UK£123.90m |
Total liabilities | UK£70.48m |
Total assets | UK£194.38m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SLNC.F's short term assets (£181.7M) exceed its short term liabilities (£14.2M).
Long Term Liabilities: SLNC.F's short term assets (£181.7M) exceed its long term liabilities (£56.3M).
Debt to Equity History and Analysis
Debt Level: SLNC.F is debt free.
Reducing Debt: SLNC.F had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SLNC.F has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: SLNC.F has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 28.8% each year.